HC Wainwright & Co. analyst Matthew Caufield reiterates IVERIC bio (NASDAQ:ISEE) with a Buy and maintains $35 price target.
Vishay Intertechnology Q2 Results Surpass Street Expectations
Vishay Intertechnology Inc (NYSE: VSH) reported
HC Wainwright & Co. Reiterates Buy on IVERIC bio, Maintains $35 Price Target
HC Wainwright & Co. analyst Matthew Caufield reiterates IVERIC bio (NASDAQ:ISEE) with a Buy and maintains $35 price target.
Related Posts
What 5 Analyst Ratings Have To Say About Automatic Data Processing
Automatic Data Processing (NASDAQ:ADP) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent…
Ipsen, Genfit’s Elafibranor Shows Promise In Primary Biliary Cholangitis Patients
Ipsen SA (OTC: IPSEY) and Genfit SA (NASDAQ: GNFT)
iPhone 15 And 15 Plus Survive The Bend Test That The iPhone 15 Pro Max Failed
If you are looking to upgrade to the iPhone 15 from the iPhone 14 or an older iPhone, you may want to check out durability tests first.